The Canadian diabetes market was valued at US$ 1.22 Billion in 2022
Canada's Diabetes Market will reach US$ 1.53 Billion by 2028 with a CAGR of 3.85% during the forecast period (2023-2028), according to the publisher. Diabetes is one of Canada's most prevalent chronic diseases, with over 11.7 million people with diabetes or prediabetes each year. It poses many challenges, such as serious complications and premature death for those affected by diabetes, and impacts health care systems. In all types of diabetes, the human body does not produce enough insulin or use the insulin it makes effectively. Therefore, each type may differ concerning its potential causes, prognosis, and treatment.
The Canadian Diabetes Industry is driven by the growing rate of obesity, spurring stress levels, and inefficient exercise within the country. The industry is further aided by the increasing high demand for insulin, which has resulted in huge R&D activities in producing various painless types of deliverable devices, like continuous glucose monitoring (CGM), integrated insulin pumps, improved new lancets products for a blood glucometer, and enormously accurate blood glucose monitoring devices.
The Canadian diabetes market is witnessing tremendous growth due to various new advancements taking place in the diabetes industry. Initially, the insulin was given through syringes, which were considered painful and hard to use. The only drawback that might affect the Canadian diabetes industry growth is the high cost of insulin pens. Canadian diabetes market was valued at US$ 1.22 Billion in 2022.
Continued Rising Trend of Type 2 Diabetes Rates in Canada
Type 2 diabetes is one of the fastest-growing diseases in Canada. As a result, Canada has an unprecedented opportunity to implement innovative policy and exercise global leadership with bold action on diabetes. Approximately 90% of all diabetes diagnoses are type 2 diabetes. In addition, Type 2 has a substantial economic burden attributable to severe micro vascular and macro vascular complications.
Moreover, More than 300,000 Canadians live with Type 1 diabetes, a chronic disease requiring patients to inject insulin and test their blood sugar throughout the day. In Dec 2021, The UBC Faculty of Medicine launched Canada's first JDRF Centre of Excellence in Type 1 diabetes research.
SMBG Devices will grow more in the Upcoming Years
Canada's Diabetes industry was classified into CGM, SMBG, and Insulin Pumps. Self-Blood glucose monitoring (SBGM) devices are helpful for patients with diabetes. SMBG is subdivided into a blood glucose meter, testing strips, and lancets. SMBG systems are small and easy to use, require small blood sample volumes, and provide measurement results within seconds. In addition, devices are increasingly equipped with connectivity to other devices, digital diaries, and diabetes management tools. CGM and Insulin pumps are also growing daily due to growing awareness about diabetes preventive care, new product launches, and supportive government initiatives.
Canada Government Initiative
The high prevalence of diabetes and its overwhelming impact on Canadian communities and the healthcare system means that further diabetes research is needed. In 2021, Canadian Government announced US$ 35 Million for five years for prevention, surveillance, and research to work development of a national framework for diabetes.
Key Company
Some key players in the Canadian diabetes market are Medtronic, Insulet Corporation, LifeScan Inc., Abbott Laboratories, Dexcom, Inc, Roche Diagnostic, and Tandem Diabetes Care.
In March 2022, the Ontario government announced it would provide coverage for the Dexcom G6 CGM System through Ontario's Assistive Devices Program (ADP) for people in the province with type 1 diabetes over two years of age and who meet coverage criteria. As a result, Ontario joins six other provinces or territories, most recently Alberta, offering public coverage of CGM systems under provincial health plans.
The report titled 'Canada Diabetes Market & Volume Forecast by SMBG (Test Strips Market, Lancet Market, Meter Market and Forecast, Blood Glucose (SMBG) Users and Blood Glucose Devices Reimbursement), CGM (Glucose Sensor Market, CGM Transmitter Market, CGM User, and Reimbursement Policies of CGM devices) Insulin Pump (Insulin Pump Market, Insulin Pump User, and Reimbursement Policies Insulin Pump), Company Analysis (Medtronic, Insulet Corporation, LifeScan Inc., Abbott Laboratories, Dexcom, Inc, Roche Diagnostic, and Tandem Diabetes Care)' provides a detailed analysis of Diabetes Market in Canada.
Canada Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pump
Segments Market based on Devices: Breakup into three parts
1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pump
1. Self-Monitoring Blood Glucose (SMBG) Device: Breakup into five parts
1. Test Strips Market
2. Lancet Market
3. Meter Market
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
2. Continuous Glucose Monitoring (CGM): Breakup into four parts
1. Glucose Sensor Market
2. CGM Transmitter Market
3. CGM User
4. CGM Reimbursement
3. Insulin Pump Market: Breakup into three parts
1. Insulin Pump Market
2. Insulin Pump Users
3. Reimbursement Policies
All the 7 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Recent Developments
- Financial Insight
Company Analysis
1. Medtronic
2. Insulet Corporation
3. LifeScan Inc.
4. Abbott Laboratories
5. Dexcom, Inc
6. Roche Diagnostic
7. Tandem Diabetes Care
Table of Contents
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Canada Diabetes Market
6. Canada Diabetes Population
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
7. Market Share - Canada Diabetes Analysis
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Canada Market & Users
8.1 Canada- CGM Market by Components
8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market
8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in Canada
9. Blood Glucose Device (SMBG) - Canada Market & Users
9.1 Market
9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market
9.2 Test Strips Market
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement Policies of Blood Glucose Devices in Canada
10. Insulin Pump -Canada Market & Users
10.1 Insulin Pump Market
10.1.1 Type 1 Diabetes Market
10.1.2 Type 2 Diabetes Market
10.2 Insulin Pump User
10.2.1 Type 1 Insulin Pump User
10.2.2 Type 2 Insulin Pump User
10.3 Differentiation Points of Insulin Pump Products in Canada
10.3.1 Animas Vibe
10.3.2 Medtronic 530G with Enlite
10.3.3 Insulet OmniPod
10.3.4 Tandem t: slim
10.3.5 Roche Accu-Chek Combo
10.4 Training Model ( Medtronic, Animas, Insulet Corp &Training to Patients & HCP)
10.4.1 Medtronic
10.4.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
10.4.1.2 Training Model for HCP (HealthCare Professional)
10.5 Insulet Corporation
10.5.1 Training Structure for New Patients - Insulet Corporation
10.6 Animas Corporation
10.6.1 Training Modules for New Patients
10.6.2 Training Modules for HCP (Health Care Professional)
10.7 Tandem Diabetes Care
10.8 Reimbursement Policies Insulin Pump
11. Insulin Pump - Company Analysis
11.1 Medtronic
11.1.1 Overview
11.1.2 Recent Developments
11.1.3 Revenue
11.2 Insulet Corporation
11.2.1 Overview
11.2.2 Recent Developments
11.2.3 Revenue
12. SMBG - Company Analysis
12.1 LifeScan Inc.
12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue
12.2 Abbott Laboratories
12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue
13. CGM - Company Analysis
13.1 Dexcom Inc
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue
13.2 Roche
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue
List of Figures:
Figure 01: Canada - Diabetes Market (Billion US$), 2017 - 2022
Figure 02: Canada - Forecast for Diabetes Market (Billion US$), 2023 - 2028
Figure 03: Canada - Type 1 Diabetes Population (Thousand), 2017 - 2022
Figure 04: Canada - Forecast for Type 1 Diabetes Population (Thousand), 2023 - 2028
Figure 05: Canada - Type 2 Diabetes Population (Thousand), 2017 - 2022
Figure 06: Canada - Forecast for Type 2 Diabetes Population (Thousand), 2023 - 2028
Figure 07: Canada - Glucose Sensor Market Market (Million US$), 2017 - 2023
Figure 08: Canada - Forecast for Glucose Sensor Market Market (Million US$), 2023 - 2028
Figure 09: Canada - CGM Transmitter Market Market (Million US$), 2017 - 2023
Figure 10: Canada - Forecast for CGM Transmitter Market Market (Million US$), 2023 - 2028
Figure 11: Canada - CGM User (Thousand), 2017 - 2023
Figure 12: Canada - Forecast for CGM User (Thousand),2023 - 2028
Figure 13: Canada - Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 14: Canada - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 15: Canada - Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 16: Canada - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 17: Canada - Test Strips Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 18: Canada - Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 19: Canada - Test Strips Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 20: Canada - Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 21: Canada - Lancet Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 22: Canada - Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 23: Canada - Lancet Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 24: Canada - Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 25: Canada - Meter Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 26: Canada - Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 27: Canada - Meter Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 28: Canada - Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 29: Canada - Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 - 2022
Figure 30: Canada - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 - 2028
Figure 31: Canada - Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 - 2022
Figure 32: Canada - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 - 2028
Figure 33: Canada - Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 34: Canada - Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 35: Canada - Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 36: Canada - Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 37: Canada - Insulin Pump Type 1 Users (Thousand), 2017 - 2022
Figure 38: Canada - Forecast for Insulin Pump Type 1 Users (Thousand), 2023 - 2028
Figure 39: Canada - Insulin Pump Type 2 Users (Thousand), 2017 - 2022
Figure 40: Canada - Forecast for Insulin Pump Type 2 Users (Thousand), 2023 - 2028
Figure 41: Medtronic - Global Revenue (Billion US$), 2017 - 2022
Figure 42: Medtronic - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 43: Insulet Corporation - Global Revenue (Million US$), 2017 - 2022
Figure 44: Insulet Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 45: LifeScan Inc. - Global Revenue (Million US$), 2017 - 2022
Figure 46: LifeScan Inc. - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 47: Abbott Laboratories - Global Revenue (Billion US$), 2017 - 2022
Figure 48: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 49: Dexcom Inc - Global Revenue (Million US$), 2017 - 2022
Figure 50: Dexcom Inc - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 51: Roche - Global Revenue (Billion US$), 2017 - 2022
Figure 52: Roche - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 53: Tandem Diabetes Care - Global Revenue (Million US$), 2017 - 2022
Figure 54: Tandem Diabetes Care - Forecast for Global Revenue (Million US$), 2023 - 2028
List of Tables:
Table 01: Canada - Diabetes Market Share by Type (Percent), 2017 - 2022
Table 02: Canada - Forecast for Diabetes Market Share by Type (Percent), 2023 - 2028
Companies Mentioned
- Medtronic
- Insulet Corporation
- LifeScan Inc.
- Abbott Laboratories
- Dexcom, Inc
- Roche Diagnostic
- Tandem Diabetes Care
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | February 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1.22 Billion |
| Forecasted Market Value ( USD | $ 1.53 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Canada |
| No. of Companies Mentioned | 7 |
